|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2010. View Article : Google Scholar
|
|
2
|
Siegel R, Ward E, Brawley O and Jemal A:
Cancer statistics, 2011: the impact of eliminating socioeconomic
and racial disparities on premature cancer deaths. CA Cancer J
Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Peng J, Yang LX, Zhao XY, Gao ZQ, Yang J,
et al: VCP gene variation predicts outcome of advanced
non-small-cell lung cancer platinum-based chemotherapy. Tumour
Biol. 34:953–961. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sánchez-Aragó M, Chamorro M and Cuezva JM:
Selection of cancer cells with repressed mitochondria triggers
colon cancer progression. Carcinogenesis. 31:567–576.
2010.PubMed/NCBI
|
|
5
|
Chatterjee A, Dasgupta S and Sidransky D:
Mitochondrial subversion in cancer. Cancer Prev Res (Phila).
4:638–654. 2011. View Article : Google Scholar
|
|
6
|
Wang H and Dai J: Changes on mitochondrial
DNA content in non-small cell lung cancer. Zhongguo Fei Ai Za Zhi.
14:141–145. 2011.(In Chinese).
|
|
7
|
Lin CS, Wang LS, Tsai CM and Wei YH: Low
copy number and low oxidative damage of mitochondrial DNA are
associated with tumor progression in lung cancer tissues after
neoadjuvant chemotherapy. Interact Cardiovasc Thorac Surg.
7:954–958. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Choi SJ, Kim SH, Kang HY, Lee J, Bhak JH,
et al: Mutational hotspots in the mitochondrial genome of lung
cancer. Biochem Biophys Res Commun. 407:23–27. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pezzotti A, Kraft P, Hankinson SE, Hunter
DJ, Buring J and Cox DG: The mitochondrial A10398G polymorphism,
interaction with alcohol consumption, and breast cancer risk. PloS
One. 4:e53562009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jin X, Zhang J, Gao Y, Ding K, Wang N, et
al: Relationship between mitochondrial DNA mutations and clinical
characteristics in human lung cancer. Mitochondrion. 7:347–353.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Malik AN, Shahni R, Rodriguez-de-Ledesma
A, Laftah A and Cunningham P: Mitochondrial DNA as a non-invasive
biomarker: accurate quantification using real time quantitative PCR
without co-amplification of pseudogenes and dilution bias. Biochem
Biophys Res Commun. 412:1–7. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kawada I, Soejima K, Watanabe H, Nakachi
I, Yasuda H, et al: An alternative method for screening EGFR
mutation using RFLP in non-small cell lung cancer patients. J
Thorac Oncol. 3:1096–1103. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Datta S, Majumder M, Biswas NK, Sikdar N
and Roy B: Increased risk of oral cancer in relation to common
Indian mitochondrial polymorphisms and Autosomal GSTP1 locus.
Cancer. 110:1991–1999. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yu M: Generation, function and diagnostic
value of mitochondrial DNA copy number alterations in human
cancers. Life Sci. 89:65–71. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yu M: Somatic mitochondrial DNA mutations
in human cancers. Adv Clin Chem. 57:99–138. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim MM, Clinger JD, Masayesva BG, Ha PK,
Zahurak ML, et al: Mitochondrial DNA quantity increases with
histopathologic grade in premalignant and malignant head and neck
lesions. Clin Cancer Res. 10:8512–8515. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang Y, Liu VW, Xue WC, Cheung AN and Ngan
HY: Association of decreased mitochondrial DNA content with ovarian
cancer progression. Br J Cancer. 95:1087–1091. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yamada S, Nomoto S, Fujii T, Kaneko T,
Takeda S, et al: Correlation between copy number of mitochondrial
DNA and clinico-pathologic parameters of hepatocellular carcinoma.
Eur J Surg Oncol. 32:303–307. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xing J, Chen M, Wood CG, Lin J, Spitz MR,
et al: Mitochondrial DNA content: its genetic heritability and
association with renal cell carcinoma. J Natl Cancer Inst.
100:1104–1112. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hsu CW, Yin PH, Lee HC, Chi CW and Tseng
LM: Mitochondrial DNA content as a potential marker to predict
response to anthracycline in breast cancer patients. Breast J.
16:264–270. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu CW, Yin PH, Hung WY, Li AF, Li SH, et
al: Mitochondrial DNA mutations and mitochondrial DNA depletion in
gastric cancer. Genes Chromosomes Cancer. 44:19–28. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Canter JA, Kallianpur AR, Parl FF and
Millikan RC: Mitochondrial DNA G10398A polymorphism and invasive
breast cancer in African-American women. Cancer Res. 65:8028–8033.
2005.
|
|
23
|
Kulawiec M, Owens KM and Singh KK: mtDNA
G10398A variant in African-American women with breast cancer
provides resistance to apoptosis and promotes metastasis in mice. J
Hum Genet. 54:647–654. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Anoopkumar-Dukie S, Conere T, Sisk GD and
Allshire A: Mitochondrial modulation of oxygen-dependent
radiosensitivity in some human tumour cell lines. Br J Radiol.
82:847–854. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Armand R, Channon JY, Kintner J, White KA,
Miselis KA, et al: The effects of ethidium bromide induced loss of
mitochondrial DNA on mitochondrial phenotype and ultrastructure in
a human leukemia T-cell line (MOLT-4 cells). Toxicol Appl
Pharmacol. 196:68–79. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yu M, Shi Y, Wei X, Yang Y, Zhou Y, et al:
Depletion of mitochondrial DNA by ethidium bromide treatment
inhibits the proliferation and tumorigenesis of T47D human breast
cancer cells. Toxicol Lett. 170:83–93. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Park SY, Chang I, Kim JY, Kang SW, Park
SH, et al: Resistance of mitochondrial DNA-depleted cells against
cell death: role of mitochondrial superoxide dismutase. J Biol
Chem. 279:7512–7520. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cloos CR, Daniels DH, Kalen A, Matthews K,
Du J, et al: Mitochondrial DNA depletion induces radioresistance by
suppressing G2 checkpoint activation in human pancreatic cancer
cells. Radiat Res. 171:581–587. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kawamura SD, Takai K, Watanabe J, Hayashi
J, Hayakawa K and Akashi M: Role of mitochondrial DNA in cells
exposed to irradiation: generation of reactive oxygen species (ROS)
is required for G2 checkpoint upon irradiation. J Health Sci.
51:385–393. 2005. View Article : Google Scholar
|
|
30
|
Kulawiec M, Ayyasamy V and Singh KK: p53
regulates mtDNA copy number and mitocheckpoint pathway. J Carcinog.
8:82009. View Article : Google Scholar : PubMed/NCBI
|
